Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics
  • the committee is based on a system of peer review
  • the committee is independent

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.

New proposals IRC

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’
  • the Gavi's strategic goals

It also ensures that each new application for support complies with the eligibility criteria, established according to the Gavi guidelines for new proposals of support.


Round opening 
(on the portal)

Deadline for submission

IRC meeting
(indicative dates)

~2mths prior

19 January 2021

8–19 March 2021

~2mths prior

4 May 2021

28 June–9 July 2021

~2mths prior

15 September 2021

8–19 Nov 2021

    IRC Membership

    Members of the Independent Review Committee consist of specialists from a broad range of expertise.

    IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

    Range of expertise

    The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

    • Routine immunisation programmes, especially at country level
    • Management of campaigns
    • Delivery of health services including child and adolescent health
    • Health systems strengthening and management
    • Epidemiology and disease control
    • Cold chain and logistics
    • Financial and budget analysis
    • Gender and equity

    The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

    Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

    List of IRC pool members



    Areas of expertise

    1 Saidou Pathé Barry HSS, national health strategies, policy dialogue in the health sector, M&E, primary health care
    2 Blaise Bikandou HSS, policy development, vaccine preventable diseases, epidemiology, health programme management and administration
    3 Francois Boilloit Disease control, health system development and reform, health financing, development assistance for health
    4 Brent Burkholder  Epidemiology, vaccine programmes and disease control, outbreak investigations
    5 Diego Buriot Public health interventions, communicable diseases, fragile and crisis settings
    6 Pierre Bwale Health care delivery, campaigns, emergencies, programmes for hard-to-reach communities
    7 Lisa Cairns Immunisation policy, epidemiology, M&R control, national immunisation programme reviews
    8 Aleksandra Caric Immunisation, vaccine safety and regulation, programme management and administration
    9 Dah Cheikh Organization and management of vaccination programmes, HSS, vaccine campaigns, trainings
    10 Sadia Chowdhury Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes
    11 Natasha Crowcroft Epidemiology, HSS, HPV, measles, outbreak control, training and capacity building
    12 Celestino Costa Cold chain, immunisation, HSS, emergency responses, primary health care
    13 John Crump  Infectious diseases, epidemiology, outbreak responses, typhoid
    14 Henrique D’Alva Cold chain, EPI logistics
    15 Kevin De Cock Global public health, HIV, emergency & outbreak response, HSS
    16 Modibo Dicko Supply chain management, introducing innovative technologies, management systems and practices in health supply systems
    17 Rene Dubbeldam National health policies, essential medicines strategies, child health programmes, community health, epidemiology
    18 Peter Fonkwo Health programme design and management, routine &mass campaigns vaccination, HSS, EPI M&E
    19 Djordie Gikic HSS, proposal development, immunisation systems evaluation, service delivery, health policies
    20 Melita Gordon Gastroenterology, disease surveillance, typhoid, vaccine trials
    21 John Grundy Health policy, campaign delivery, HSS, programme evaluation
    22 Bradley Hersh Health policy, immunisation, outbreaks, campaigns, measles control
    23 Natasha Howard Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background
    24 Hector Izurieta Immunisation campaign management, public health, measles control, epidemiology, policy making
    25 Clifford Kamara Health development, immunisation services, recovery programme, management and evaluation of health programmes
    26 Jean Rostand Kamga Financial & budget analysis, management and governance, audits, financial investigations
    27 Toagoe Karzon Project funding, financial reporting and budget control, conducting audits
    28 Tcha Landry Kaucley Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management
    29 Wassim Khrouf Financial & budget analysis, audits, project assessment
    30 Vladimir Lazarevik Healthcare system transformation, health financing design, health policy development
    31 Stefano Lazzari Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management
    32 Dafrossa Lyimo Immunisation campaign management, public health, health systems management, health policies, disease control
    33 Osman Mansoor Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics
    34 Viviana Mangiaterra Child health, epidemiology, HSS, immunisation programmes
    35 Florian Marks  Public health, vaccinology and policy making, outbreak responses, campaign evaluations
    36 Tawanda Marufu Fragile settings, HSS, epidemiology, health policy, HPV, Typhoid, measles
    37 Scott McKeown Epidemiology, information systems, health service delivery, immunization incl. campaigns, cold chain maintenance
    38 Mark Miller Epidemiology, vaccine research, public health, outbreak investigations, disease control
    39 Kondwani Msampha Financial & budget analysis, HSS, global health and integrated service delivery
    40 Benjamin Nkowane Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health
    41 Mathieu Noirhomme Public health, HSS, health policy dialogue, health financing, design thinking & service design, universal health coverage
    42 Peter Nsubuga Epidemiology, measles control, cold chain, HSS
    43 Cornelius Oepen HSS, urban health, health security, mass vaccination/campaigns, evaluation of research programmes
    44 Jean Marc Olive Immunisation programmes, emergency strategies & disaster relief, measles elimination
    45 Virgil Onama Project design, M&E, results-based management, health financing & policy, fragile settings
    46 Michael Park Programme management and evaluation, primary care, health systems and public health
    47 Elisabeth Paul   Health systems and policies, health financing, universal health coverage, performance-based financing, aid effectiveness
    48 Ian Pett Health care, cold chain, HSS, outbreak response, emergencies
    49 Arthur Reingold Epidemiology, measles control, vaccination delivery, strengthening health infrastructure
    50 Cheikh Mohamed Hafis Seck Financial & budget analysis, financial management of donor-funded programs, audit, grant agreements
    51 Jim Setzer  Health information systems, HSS, disease surveillance, programme and policy planning, M&E, strategic planning
    52 Craig Shapiro Management of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities
    53 Simon (Sam) Sternin Global health generalist, HSS, disaster management, coverage and equity, CSOs
    54 Abdelmajid Tibouti Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation
    55 Vivien Tsu  Epidemiology, new public health interventions, women's reproductive health, HPV, JE
    56 Margaret Watkins Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations
    57 Karen Wilkins Immunisation campaign management, proposals development, monitoring and evaluation, DQ assessments
    58 Aregai Woldegebriel Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation


    Consolidated IRC reports

    November 27, 2019

    IRC reports

    Last updated: 14 Jan 2021

    Subscribe to our newsletter